Suppr超能文献

肾小球内压力在肾脏疾病发生和进展中的作用。

The role of intraglomerular pressure in the initiation and progression of renal disease.

作者信息

Anderson S, Brenner B M

出版信息

J Hypertens Suppl. 1986 Dec;4(5):S236-8.

PMID:3033176
Abstract

Reduction in functioning nephron number leads to progressive renal disease. A haemodynamic basis for this process has been suggested by studies of partially nephrectomized rats. In this model compensatory hyperfiltration in the remnant nephrons due to increases in the glomerular capillary hydraulic pressure (-PGC) and plasma flow rate is associated with eventual glomerular sclerosis. Therapeutic attenuation of these haemodynamic adaptations protects against glomerular injury. One such therapy is angiotensin converting enzyme (ACE) inhibition, which lowers systemic blood pressure and -PGC and prevents sclerosis in rats with renal ablation, as well as in the hyperfiltering kidneys of normotensive rats with diabetes mellitus. Control of -PGC with ACE inhibitor is also protective even when therapy is delayed until systemic hypertension and glomerular injury are established. In contrast, the control of systemic hypertension but not -PGC affords no protection in remnant kidney rats. Thus, control of glomerular hypertension slows the progression of renal disease.

摘要

功能性肾单位数量减少会导致进行性肾脏疾病。对部分肾切除大鼠的研究提示了这一过程的血流动力学基础。在该模型中,由于肾小球毛细血管液压(-PGC)和血浆流速增加,残余肾单位会发生代偿性超滤,这与最终的肾小球硬化有关。对这些血流动力学适应的治疗性减弱可预防肾小球损伤。其中一种治疗方法是抑制血管紧张素转换酶(ACE),它可降低全身血压和-PGC,并预防肾切除大鼠以及患有糖尿病的正常血压大鼠的高滤过肾脏发生硬化。即使在全身高血压和肾小球损伤已经形成后才开始治疗,用ACE抑制剂控制-PGC也具有保护作用。相比之下,控制全身高血压而不控制-PGC对残余肾大鼠没有保护作用。因此,控制肾小球高血压可减缓肾脏疾病的进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验